Kedrion Biopharma
Claudio Bugatti is a highly experienced professional in project management and engineering, currently serving as Global Engineering & EHSS Sr. Director and Global Capital Projects Director at Kedrion Biopharma since November 2017, responsible for project portfolio management and capital planning. Prior to this, Claudio held various roles at GSK from October 2006 to November 2017, including Site PMO & Strategy Deployment Head, where accountability included managing site project portfolios and strategy deployment, and Global Project Manager for significant projects such as the GSK Worthing Site Remediation Programme. Earlier experience includes positions at Techint as a Project Engineer and at STERLING S.P.A. as Site Engineering & Maintenance Manager and Process Engineer. Claudio holds a Postgraduate Master in Project Management from MIP Politecnico di Milano and a Master of Science in Chemical Engineering from Alma Mater Studiorum – Università di Bologna.
This person is not in the org chart
This person is not in any teams
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.